Trauma Exposure and Depression among Frontline Health Professionals During COVID-19 Outbreak in China: The Role of Intrusive Rumination and Organizational Silence
Abstract Background: Healthcare professionals are a population exposed to especially high riskand stress during the COVID-19 outbreak. Several studies have demonstrated that healthcare professionals exposed to COVID-19 reported various affective disorders such as depressive symptoms, anxiety, insomnia, and distress. However, the mechanism underlying the association between trauma exposure and depressive symptom among frontline hospital staff has yet to be investigated. This study aims to assess the prevalence of depressive symptoms among frontline healthcare professionals in Shenzhen, China, particularly examining its association with trauma exposure, intrusive rumination and organizational silence.Methods: Data of the study came from a time-lagged panel questionnaire survey with three waves of measurement from February, 2020 to May, 2020 at an infectious diseases hospital of Shenzhen which accommodated all the confirmed cases of COVID-19 patients. Using clustersampling design, a total of 134 frontline healthcare professionals directly involved inproviding diagnosis, treatment and nursing services for COVID-19 patients completed three wave web survey. A moderated mediation model was performed to examine the complex interplay among the major study variables.Results: Trauma exposure was significantly related with depression of frontline healthcare professionals. Intrusive rumination mediated the effect of trauma exposure on depressive symptom, and organization silence moderated the relationship between intrusive rumination and depressive symptoms. Intrusive rumination showed stronger effect on depressive while organization silences was at a lower level.Conclusions: This research demonstrates the pivotal role that intrusive rumination and organizational silence play in predicting the depressive symptoms among the frontline healthcare professionals coping with COVID-19.